FDA inspection
MPP PHARMA LLC: FDA inspection ending Apr 2, 2026
FDA inspection 1310538 · Official Action Indicated (OAI) · Kansas City, MO
Key facts
| Inspection ID | 1310538 |
|---|---|
| Firm | MPP PHARMA LLC |
| FEI number | 1930436 |
| Address | 1800 N Topping Ave |
| City | Kansas City |
| State | MO |
| ZIP | 64120 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Apr 2, 2026 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data